Background: Mycoplasma pneumoniae (MP) is a common cause of community-acquired pneumonia in children, and it has been associated with wheezing. The aim of this study was to examine the serum level of interleukin (IL)-4 and IL-10 in children with Mycoplasma pneumoniae pneumonia (MPP) and to analyse them in relation to the presence of wheezing. Methods: The study included 166 children with radiologically confirmed pneumonia. MP infection was confirmed by enzyme-linked immunosorbent assay (ELISA) serum MP-IgM and MP-IgG test and throat swab MP DNA with real-time polymerase chain reaction. Serum levels of IL-4 and IL-10 were measured using ELISA. Results: There was no significant difference in serum level of IL-4 between children with MPP and those with non-MPP. Among children with MPP, we found similar level of IL-4 regardless of the personal and family history of allergy and asthma or the presence of wheezing. A significantly higher level of IL-10 was found in children with MPP than in children with non-MPP (32.92618.582 vs. 27.01614.100 pg/ml, p ¼0.022). Furthermore, wheezing children with MPP had a significantly higher level of IL-10 than children with MPP without wheezing (43.75626.644 vs. 27.50610.211 pg/ml, p¼0.027). Conclusion: Our results show significantly increased serum level of IL-10 in children with MPP, which was significantly higher in children with wheezing. These findings may suggest a role of IL-10 in the pathogenesis of MPP and in the occurrence of wheezing during acute MP infection.
I N T R O D U C T I O N
Mycoplasma pneumoniae (MP) is a frequent cause of acute respiratory infections in both children and adults. It causes up to 40% of community-acquired pneumonia (CAP) in children and about 18% of infections in patients requiring hospitalization [1] . The immunopathogenesis and pathophysiological mechanisms of Mycoplasma pneumoniae pneumonia (MPP) are not fully understood yet. According to the literature, one important component of MP infection is the induction of various cytokines [2, 3] . A number of studies have shown a significant role of Th1 cytokines in the pathogenic mechanisms of MPP [4] [5] [6] [7] . However, some researchers have highlighted the importance of interleukin (IL)-5, Th2-type cytokine during the pathogenesis of MP infection and occurrence of wheezing [8, 9] . Moreover, infection with MP has been associated with wheezing [10] and multiple aspects of asthma [11] , where predominant is Th2 cytokine response [12] . Therefore, we conducted a study to examine the serum level of Th2 cytokines, IL-4 and IL-10 in children with MPP and to analyse them in relation to the presence of wheezing.
M A T E R I A L S A N D M E T H O D S
Children aged between 1 and 15 years with symptoms, signs and chest radiographs consistent with CAP examined in the Emergency Department of University Children's Hospital in Belgrade from April 2012 to March 2014 were prospectively enrolled in this cross-sectional study. Pneumonia was defined as the presence of fever, acute respiratory symptoms (cough, tachypnoea and difficult breathing) or both, plus presence of new infiltrate on chest radiography or consolidation not attributable to some other aetiology [13] . Exclusion criteria were severe concomitant disease (chronic pulmonary disease except asthma, cardiovascular disease, neoplasia, kidney or liver disease and immunodepression), nosocomial-acquired infection and use of antimycoplasma therapy.
This study was approved by Ethics Committee of University Children's Hospital in Belgrade and by Ethics Committee of Medical Faculty, University of Belgrade. All procedures performed in the study were in accordance with the ethical principles of Helsinki Declaration. Patients were enrolled in study after written informed consent had been obtained from their parents or guardians.
Demographic and clinical data were collected uniformly from all children who were included in the study. The evaluation of these patients includes a personal and family history of allergy or asthma.
Throat swabs taken from all children at enrolment were assessed by real-time polymerase chain reaction (RT-PCR) for the presence of MP. Samples for RT-PCR testing were obtained from oropharynx at the posterior pharyngeal wall by a cotton-tipped swab and transferred to a tube containing a commercial transport medium (Copan Italia SPA, Brescia, Italy). The specimen tube was then transported on ice to the laboratory on the same day of collection and stored at À70 C until PCR processing, which was previously described [14] .
Blood samples were obtained from all children at the time of enrolment and 2-4 weeks after. MP-specific IgM and IgG antibodies were determined using a commercially available enzyme-linked immunosorbent assay (ELISA Euroimmun, Lübeck, Germany) as previously reported [14] . Acute MP infection was diagnosed if the child had a significant antibody response (IgM antibodies detected >1.1 in single serum or if at least 4-fold increase in the IgG antibody titre detected in the paired sera) and/or if throat swabs were RT-PCR-positive [8, 10, 15] .
Serum levels of IL-4 and IL-10 were measured in samples obtained at enrolment using an ELISA (R&D Systems, Minneapolis, USA) according to the manufacturer's instruction. The kits were able to detect concentrations as low as 10 pg/ml of IL-4 and 3.9 pg/ml of IL-10. All assays were run in duplicate, and the mean value was used for statistical analysis.
Statistical analysis
Student's t-test and Mann-Whitney U-test were used to compare continuous variables between the group, and v 2 test and Fisher's exact test were used for categorical variables. Multiple regression analyses were performed to assess the contribution of age, sex and personal or family history of allergy or asthma to both IL-4 and IL-10 level. The relationship between ILs and laboratory data was analysed using Pearson's correlation coefficient. The diagnostic accuracy of IL-10 in discriminating between MPP and non-MP pneumonia was compared by constructing receiver operating characteristic (ROC) curve. A p value of <0.05 was considered statistically significant. Statistical analyses were performed with SPSS version 20.0 software.
R E S U L T S
Demographic characteristics of children with MPP and those with non-MP pneumonia are presented in Table 1 .
Analysing the level of IL-4 in our study groups, we found that there was no significant difference in serum level of IL-4 between children with MPP and those with non-MPP (Table 2) . Moreover, in the group of children with MPP, we evaluated the level of IL-4 in relation to personal and family history of allergy or asthma (Table 3 ). No significant difference was observed in serum level of IL-4 between children with MPP who did or did not have personal or family history of allergy or asthma. As shown in Table 3 in the group of children with MPP, we did not observe significant difference in the level of IL-4 between children with wheezing and children without wheezing. Furthermore, we evaluated the level of IL-10 in children with CAP. A significantly higher level of IL-10 (p ¼ 0.022) was found in children with MPP than in children with non-MPP ( Table 2 ). In the MPP group, we did not observe significant difference in the level of IL-10 between children with and without personal or family history of allergy or asthma (Table 3) . Among children with MPP, the level of IL-10 in the wheezing children was significantly higher than in children without wheezing (p ¼ 0.027; Table 3 ). However, there was no significant difference between children with and without wheezing in the non-MPP group (28.42 6 11.317 vs. 32.82 6 10.54, p ¼ 0.700).
In multiple regression analyses, none of age, sex and personal or family history of allergy or asthma was found to contribute to either IL-4 or IL-10 level.
Moreover, we analysed the correlations between IL-10 and clinical or laboratory data. There was no significant correlation between IL-10 and total WBC count (r ¼À0.182, p ¼ 0.393), between IL-10 and CRP level (r ¼À0.256, p ¼ 0.227) or between IL-10 and fever magnitude (r ¼ 0.079, p ¼ 0.713).
Additionally, an ROC curve analysis was carried out to assess the serum levels of IL-10 in children with MPP (Fig. 1) . The ROC curve showed that 23.50 pg/ml was the most adequate cut-off point of IL-10 in MPP. Under such a cut-off sensitivity and specificity were 58. atopic diseases such as allergies and asthma [15] .
Results of many studies have provided evidence linking MP infection and asthma [11] . However, data regarding Th2 cytokine secretion, including IL-4 in children with MPP are controversial. Kita et al. [2] could not identify the production of IL-4 in response to MP in human blood cells. A murine model of MP respiratory infection showed that IL-4 was not significantly elevated neither in sera [5] nor in bronchoalveolar lavage (BAL) fluid [4, 16] . Other in vitro studies showed that these findings are not constant [3, 17] . Koh et al. found that levels of IL-4 and IL-4/ interferon-c ratio in BAL fluid were significantly higher in children with MPP compared with children with pneumococcal pneumonia or children without pneumonia. They concluded that those founding suggests a predominant Th2 cytokine response in children MPP [18] . However, we found that respiratory MP infection did not increase serum secretion of IL-4 in children with CAP. Those differences in cytokine profiles between alveolar fluid and serum may reflect distinct host cell-type-specific responses [15] . Furthermore, it was shown that timing of MP infection may influence the IL-4 response [19] .
Our results are also in accordance with some of previously published studies. Choi et al. [9] reported that there was no difference in serum level of IL-4 between wheezing children with MPP, children with MPP without wheezing and children with non-MPP. Among children with MP infection, Esposito et al. [8] found similar serum level of IL-4 regardless of the presence of wheezing. Michelow et al. observed that there was no difference in the concentration of IL-4 between groups of children with CAP caused by atypical bacteria, Streptococcus pneumoniae, viruses or unidentified pathogens. Consistent with our results, they did not find significant difference in concentration of IL-4 between children infected with atypical bacteria who did or did not have a wheezing [20] . Additionally, Woolard et al. in murine model observed that airway obstruction and airway hyperresponsiveness, which develops after MP infection, were independent of IL-4 [21] . Therefore, it is likely that other Th2 cytokines or other inflammatory process is responsible for increased airway hyperresponsiveness in patients with MP infection.
IL-10 is an anti-inflammatory cytokine. Secreted by Th2 cells, it targets macrophages to suppress the cytokine production, and consequently indirectly suppress the cytokine production by Th1 cells [15] . Results of in vitro studies regarding IL-10 are controversial as well. Pietsch et al. [22] and, recently, Kurata et al. [23] found that MP infection induces significant increase in the expression of IL-10 mRNA in lung tissues. Furthermore, Liu et al. [24] showed that capsular polysaccharide of MP promotes dendritic cell to secret IL-10. However, other authors did not find elevated IL-10 levels in BAL fluids [4] or in sera [5] . Present study, on the contrary, shows that children with MPP had increased serum level of IL-10. Recently, two clinical studies found that the level of IL-10 was significantly higher in BAL fluid in children with MPP compared with children without pneumonia [25, 26] . Different from those studies, we compared level of IL-10 between children with MPP and children with non-MPP expecting some additional information on pathogenesis specific for MPP and occurrence of wheezing. It is not possible to attribute the cytokine levels specifically to some pathogen in the absence of pneumonia attributable to another pathogen for comparison. Although we evaluated cytokine levels in serum not in BAL fluid, which may more adequately reflect local immune response within the respiratory tract, this method is of limited use in children because of ethical or technical reasons. Moreover, Ding et al. [27] recently found that the serum level of IL-10 was significantly higher in children with MPP compared with non-infected controls.
Our data suggest that children with MPP have significantly increased serum level of IL-10. Fact that all children in our study had mild disease without complications could have contributed to this observation, considering that IL-10 has anti-inflammatory role. Although IL-10 is an anti-inflammatory cytokine, we did not find significant correlations between IL-10 and CRP level, WBC count or fever magnitude. Ding et al. [27] recently reported the same observation. However, these authors found that serum level of IL-10 was significantly lower in children with severe MPP than in children with mild MPP [27] . Furthermore, it was found that IL-10 is essential for resolution of lung inflammation and recovery in Klebsiella pneumoniae pneumonia [28] .
Another important finding in our study is that we observed that wheezing children with MPP had a significantly higher level of IL-10 than children with MPP who did not have a wheezing, suggesting that those cytokines may be involved not only in the pathogenesis of MPP but also in the occurrence of wheezing during MP infection. However, the fact that half of children with MPP had asthma or allergy could have influenced to our results, but there was no significant difference in the level of IL-10 between children with and without of allergy or asthma. Therefore, we believe that our finding is not attributable to this factor because the same trend was not shown in non-MPP group. Children with non-MPP had high incidence of asthma or allergy as well, and no significant difference was found between children with and without wheezing. Besides, multiple regression analyses did not change our results.
Our study had some limitations. One of them is the significant difference between number of patients in two groups, low number of children with MPP and large number of children with non-MPP. Furthermore, we did not assess the serum level of ILs in the pre-infection stage, to rule out some other Fig. 1 . An ROC curve for serum IL-10 levels. Sensitivity and specificity were 58.3 and 59.2%, respectively (95% confidence interval¼0.537-0.754; AUC¼0.646) at 23.50 pg/ml, the most adequate cut-off point of factors that might have some influence on cytokine profile.
In conclusion, the present study as well as many previously published studies indicated that the pathogenesis of MP infections is complex. It still remains poorly defined and understood. Despite the small sample size, our data suggest that children with those infections have a specific cytokine profile that is characterized by a significant increase in serum level of IL-10, which was significantly higher in children with wheezing. These findings may suggest a role of IL-10 in the pathogenesis of MPP and in the occurrence of wheezing during acute MP infection. A prospective, larger studies are required to assess the duration of IL-10 response in children with MPP.
F U N D I N G
This work was financially supported by the ministry of Science and Technological Development of the Republic of Serbia (grant number 175039).
